Skip to content

Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology

Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02279290
Enrollment
58
Registered
2014-10-31
Start date
2015-07-13
Completion date
2019-04-26
Last updated
2021-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Keywords

Childhood trauma

Brief summary

This randomized controlled trial uses a modularized cognitive behavioral resilience training (MCBRT) intervention to probe risk and resilience mechanisms linked to post-trauma psychopathology. Ninety participants with a history of interpersonal trauma during childhood or adolescence and mild to moderate distress will be randomized to MCBRT or a health education control condition. The primary aims of this proposal are to examine whether individuals who receive MCBRT demonstrate increases in psychological resilience, biological resilience, and extinction learning compared to those in the control group. This study will also explore associations between these psychobiobehavioral risk and resilience factors.

Interventions

BEHAVIORALHealthy Mind Intervention (HMI)

Healthy Mind Intervention (HMI) is a flexible cognitive-behavioral resilience building program. Participants will receive 8 weekly, 60-minute individual sessions of HMI. In HMI, participants will be able to select 3 areas of resilience that they want to work on.

BEHAVIORALHealthy Body Intervention (HBI)

The 8 weekly, 60-minute individual sessions will include the following topics: the mind-body connection, nutrition, exercise, unhealthy substances, sleep, preventing illness, and preventive care. Each session is spent providing didactic information on these topics and strategies for how to engage in behavior change in these areas.

Sponsors

Rush University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years of age or older 2. fluent in English 3. history of childhood interpersonal trauma (e.g., sexual assault, physical assault, witnessing assault before age 18) 4. mild to moderate distress indicated by a score of 10-20 on the depression scale, 8-14 on the anxiety scale, or 15-25 on the stress scale of the DASS-21.

Exclusion criteria

1. severe distress indicated by a score \>20 on the depression scale, \>14 on the anxiety scale, or \>25 on the stress scale of the DASS-21 2. DSM-5 criterion A trauma in the past month 3. color blindness based on self-report (because of inability to complete the fear conditioning task) 4. auditory impairment based on audiometer screening (because of inability to complete the fear conditioning task) 5. lifetime psychotic or bipolar disorder 6. substance abuse or dependence within past 6 months 7. concurrent psychotherapy initiated within 3 months of randomization 8. ongoing psychotherapy of any duration directed toward treatment of trauma-related psychopathology (e.g., CBT) 9. must be on a stable dose of psychotropic or adrenergically-active medications (e.g., beta blockers) for at least 6 weeks prior to eligibility screening 10. mental retardation or significant cognitive impairment 11. serious medical illness or instability for which hospitalization may be likely within the next year 12. significant suicidal ideation indicated by yes on Columbia Suicide Severity Rating Scale item 4 (active suicidal ideation with some intent to act) or enacted suicidal behaviors within 6 months prior to eligibility 13. current legal actions related to trauma.

Design outcomes

Primary

MeasureTime frameDescription
Psychological resilience outcomes include emotion regulation (DERS), hardiness (CD-RISC), optimism (LOT-R), perceived control (SMS), social support (MSPSS), and task-oriented coping (CISS-SFT).0 - 9 weeksDifference between the interventions in the change of psychological resilience from pre to post intervention.
Biological resilience outcomes include neuropeptide Y [NPY], dehydroepiandrosterone [DHEA], allopregnanolone [ALLO] taken from a blood draw.0-9 weeksDifference between the interventions in the change of biological resilience from pre to post intervention.
Extinction learning will be analyzed using the fear potentiated startle data from a fear conditioning paradigm.0-9 weeksDifference between the interventions in the change of extinction learning from pre to post intervention.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026